AnaptysBio Adds More Shares, Raises $75M in Stock Market Debut
Xconomy
JANUARY 26, 2017
As has been the case for biotechs over the past year , insiders helped Anaptys get to the public market. The San Diego-based company sold 5 million shares at $15 apiece—in line with the $14 to $16 per share range it set earlier this month—and is now trading on the Nasdaq under the symbol “ANAB.”
Let's personalize your content